Previous 10 | Next 10 |
2024-04-12 13:17:44 ET Short percentage in S&P 500’s healthcare companies surged in the end of March from February, as the life science tools and services sub-sector saw a jump in short interest from the previous month.... Read the full article on Seeking Alpha For fu...
2024-04-12 12:02:53 ET More on AbbVie, Biogen, etc. AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67% Novo Nordisk: The Moat Won't Last Forever AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision No link between weight...
2024-04-12 07:05:43 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk: The Moat Won't Last Forever Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Roche, Eli Lilly gain ...
2024-04-11 18:33:21 ET Shares of Swiss pharmaceuticals giant Roche Holdings (OTC: RHHBY) stock popped 2.5% in early trading Thursday before giving back about half of its gains. Roche announced this morning that the U.S. Food and Drug Administration has awarded the "Breakthrough ...
2024-04-11 06:20:37 ET Roche ( OTCQX:RHHBY ) and partner Eli Lilly ( NYSE: LLY ) have received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for their Elecsys pTau217 assay to support early diagnosis of Alzheimer's disease.... Read th...
2024-04-10 14:56:07 ET More on Markets OKE and F: The only 5% dividend stocks within the S&P 500 that are beating the index YTD 10-year yield tops 4.5% after strong CPI report Chances of June rate cut narrow after hot CPI print CPI inflation stays hot in ...
2024-04-10 01:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Although technology an...
2024-04-09 14:08:15 ET Cabot Wealth published its Cabot Top Ten Trader stocks, and Arm Holdings ( ARM ) is this week’s top pick.... Read the full article on Seeking Alpha For further details see: Cabot’s Top Ten list of stocks
2024-04-09 13:06:07 ET More on Eli Lilly Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets EMA to ...
2024-04-09 12:37:13 ET More on Structure Therapeutics Seeking Alpha’s Quant Rating on Structure Therapeutics Historical earnings data for Structure Therapeutics Financial information for Structure Therapeutics Read the full article on Seeking Alpha ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...